nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—Balsalazide—Crohn's disease	0.265	0.335	CbGbCtD
Zafirlukast—PTGS1—Mesalazine—Crohn's disease	0.212	0.268	CbGbCtD
Zafirlukast—ABCG2—Sulfasalazine—Crohn's disease	0.128	0.162	CbGbCtD
Zafirlukast—PTGS1—Sulfasalazine—Crohn's disease	0.118	0.15	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—Crohn's disease	0.0458	0.0579	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—Crohn's disease	0.0222	0.028	CbGbCtD
Zafirlukast—Eosinophilic pneumonia—Mesalazine—Crohn's disease	0.011	0.0872	CcSEcCtD
Zafirlukast—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00432	0.0341	CcSEcCtD
Zafirlukast—Liver injury—Mercaptopurine—Crohn's disease	0.00397	0.0313	CcSEcCtD
Zafirlukast—Upset stomach—Mesalazine—Crohn's disease	0.00276	0.0218	CcSEcCtD
Zafirlukast—Hepatotoxicity—Azathioprine—Crohn's disease	0.00257	0.0203	CcSEcCtD
Zafirlukast—Throat sore—Mesalazine—Crohn's disease	0.00251	0.0199	CcSEcCtD
Zafirlukast—Blister—Mesalazine—Crohn's disease	0.00251	0.0199	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.00249	0.0197	CcSEcCtD
Zafirlukast—Liver injury—Azathioprine—Crohn's disease	0.00236	0.0187	CcSEcCtD
Zafirlukast—Hepatotoxicity—Mesalazine—Crohn's disease	0.00235	0.0185	CcSEcCtD
Zafirlukast—Blood disorder—Mesalazine—Crohn's disease	0.00217	0.0171	CcSEcCtD
Zafirlukast—Liver injury—Mesalazine—Crohn's disease	0.00215	0.017	CcSEcCtD
Zafirlukast—Vasculitis—Azathioprine—Crohn's disease	0.00204	0.0161	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Mesalazine—Crohn's disease	0.002	0.0158	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00199	0.0157	CcSEcCtD
Zafirlukast—Influenza like illness—Mesalazine—Crohn's disease	0.00176	0.0139	CcSEcCtD
Zafirlukast—Neuropathy—Mesalazine—Crohn's disease	0.0017	0.0134	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00165	0.013	CcSEcCtD
Zafirlukast—Hepatic failure—Azathioprine—Crohn's disease	0.00161	0.0127	CcSEcCtD
Zafirlukast—Hepatic failure—Mesalazine—Crohn's disease	0.00146	0.0116	CcSEcCtD
Zafirlukast—Dermatitis bullous—Mesalazine—Crohn's disease	0.00138	0.0109	CcSEcCtD
Zafirlukast—Arthralgia—Mercaptopurine—Crohn's disease	0.00124	0.00981	CcSEcCtD
Zafirlukast—Liver function test abnormal—Mesalazine—Crohn's disease	0.00121	0.00959	CcSEcCtD
Zafirlukast—Abdominal discomfort—Azathioprine—Crohn's disease	0.0012	0.00945	CcSEcCtD
Zafirlukast—Oedema—Mercaptopurine—Crohn's disease	0.00119	0.00941	CcSEcCtD
Zafirlukast—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00117	0.00921	CcSEcCtD
Zafirlukast—Eosinophilia—Mesalazine—Crohn's disease	0.00112	0.00889	CcSEcCtD
Zafirlukast—Contusion—Prednisone—Crohn's disease	0.0011	0.00868	CcSEcCtD
Zafirlukast—Abdominal discomfort—Mesalazine—Crohn's disease	0.00109	0.00861	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00108	0.00857	CcSEcCtD
Zafirlukast—Neutropenia—Mesalazine—Crohn's disease	0.00106	0.00839	CcSEcCtD
Zafirlukast—Agranulocytosis—Azathioprine—Crohn's disease	0.00104	0.0082	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00103	0.00812	CcSEcCtD
Zafirlukast—Haemoglobin—Azathioprine—Crohn's disease	0.001	0.00793	CcSEcCtD
Zafirlukast—Haemorrhage—Azathioprine—Crohn's disease	0.000998	0.00789	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000993	0.00785	CcSEcCtD
Zafirlukast—Jaundice—Mesalazine—Crohn's disease	0.000987	0.0078	CcSEcCtD
Zafirlukast—Vasculitis—Prednisone—Crohn's disease	0.000982	0.00776	CcSEcCtD
Zafirlukast—Sinusitis—Mesalazine—Crohn's disease	0.00095	0.00751	CcSEcCtD
Zafirlukast—Agranulocytosis—Mesalazine—Crohn's disease	0.000945	0.00747	CcSEcCtD
Zafirlukast—Body temperature increased—Mercaptopurine—Crohn's disease	0.000941	0.00744	CcSEcCtD
Zafirlukast—Haemoglobin—Mesalazine—Crohn's disease	0.000914	0.00722	CcSEcCtD
Zafirlukast—Hepatitis—Mesalazine—Crohn's disease	0.000909	0.00719	CcSEcCtD
Zafirlukast—Haemorrhage—Mesalazine—Crohn's disease	0.000909	0.00719	CcSEcCtD
Zafirlukast—Neuropathy—Prednisone—Crohn's disease	0.0009	0.00711	CcSEcCtD
Zafirlukast—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000877	0.00693	CcSEcCtD
Zafirlukast—Diarrhoea—Mercaptopurine—Crohn's disease	0.000815	0.00644	CcSEcCtD
Zafirlukast—Ill-defined disorder—Azathioprine—Crohn's disease	0.000806	0.00637	CcSEcCtD
Zafirlukast—Malaise—Azathioprine—Crohn's disease	0.000784	0.00619	CcSEcCtD
Zafirlukast—Back pain—Mesalazine—Crohn's disease	0.000766	0.00605	CcSEcCtD
Zafirlukast—Vomiting—Mercaptopurine—Crohn's disease	0.000757	0.00598	CcSEcCtD
Zafirlukast—Injury—Prednisone—Crohn's disease	0.000757	0.00598	CcSEcCtD
Zafirlukast—Rash—Mercaptopurine—Crohn's disease	0.000751	0.00593	CcSEcCtD
Zafirlukast—Dermatitis—Mercaptopurine—Crohn's disease	0.00075	0.00593	CcSEcCtD
Zafirlukast—Arthralgia—Azathioprine—Crohn's disease	0.00074	0.00585	CcSEcCtD
Zafirlukast—Myalgia—Azathioprine—Crohn's disease	0.00074	0.00585	CcSEcCtD
Zafirlukast—Ill-defined disorder—Mesalazine—Crohn's disease	0.000735	0.0058	CcSEcCtD
Zafirlukast—Discomfort—Azathioprine—Crohn's disease	0.000731	0.00578	CcSEcCtD
Zafirlukast—Angioedema—Mesalazine—Crohn's disease	0.000723	0.00572	CcSEcCtD
Zafirlukast—Malaise—Mesalazine—Crohn's disease	0.000714	0.00564	CcSEcCtD
Zafirlukast—Nausea—Mercaptopurine—Crohn's disease	0.000707	0.00559	CcSEcCtD
Zafirlukast—Infection—Azathioprine—Crohn's disease	0.000705	0.00557	CcSEcCtD
Zafirlukast—Thrombocytopenia—Azathioprine—Crohn's disease	0.000694	0.00549	CcSEcCtD
Zafirlukast—Arthralgia—Mesalazine—Crohn's disease	0.000674	0.00533	CcSEcCtD
Zafirlukast—Myalgia—Mesalazine—Crohn's disease	0.000674	0.00533	CcSEcCtD
Zafirlukast—Discomfort—Mesalazine—Crohn's disease	0.000666	0.00526	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000646	0.00511	CcSEcCtD
Zafirlukast—Oedema—Mesalazine—Crohn's disease	0.000646	0.00511	CcSEcCtD
Zafirlukast—Infection—Mesalazine—Crohn's disease	0.000642	0.00507	CcSEcCtD
Zafirlukast—Thrombocytopenia—Mesalazine—Crohn's disease	0.000633	0.005	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000612	0.00484	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000589	0.00465	CcSEcCtD
Zafirlukast—Feeling abnormal—Azathioprine—Crohn's disease	0.000585	0.00462	CcSEcCtD
Zafirlukast—Insomnia—Mesalazine—Crohn's disease	0.000584	0.00462	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00058	0.00458	CcSEcCtD
Zafirlukast—Dyspepsia—Mesalazine—Crohn's disease	0.000569	0.00449	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—Crohn's disease	0.000562	0.00444	CcSEcCtD
Zafirlukast—Abdominal pain—Azathioprine—Crohn's disease	0.000561	0.00443	CcSEcCtD
Zafirlukast—Body temperature increased—Azathioprine—Crohn's disease	0.000561	0.00443	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000558	0.00441	CcSEcCtD
Zafirlukast—Fatigue—Mesalazine—Crohn's disease	0.000557	0.0044	CcSEcCtD
Zafirlukast—Pain—Mesalazine—Crohn's disease	0.000553	0.00437	CcSEcCtD
Zafirlukast—Feeling abnormal—Mesalazine—Crohn's disease	0.000532	0.00421	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000528	0.00417	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—Crohn's disease	0.000525	0.00415	CcSEcCtD
Zafirlukast—Hypersensitivity—Azathioprine—Crohn's disease	0.000523	0.00413	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—JAK2—Crohn's disease	0.000517	0.00632	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000516	0.00631	CbGpPWpGaD
Zafirlukast—Urticaria—Mesalazine—Crohn's disease	0.000513	0.00406	CcSEcCtD
Zafirlukast—Body temperature increased—Mesalazine—Crohn's disease	0.000511	0.00404	CcSEcCtD
Zafirlukast—Abdominal pain—Mesalazine—Crohn's disease	0.000511	0.00404	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—MLN—Crohn's disease	0.000499	0.0061	CbGpPWpGaD
Zafirlukast—Diarrhoea—Azathioprine—Crohn's disease	0.000485	0.00383	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—Crohn's disease	0.000484	0.00382	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—Crohn's disease	0.000481	0.0038	CcSEcCtD
Zafirlukast—Hypersensitivity—Mesalazine—Crohn's disease	0.000476	0.00376	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000474	0.00579	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000472	0.00578	CbGpPWpGaD
Zafirlukast—Dizziness—Azathioprine—Crohn's disease	0.000469	0.00371	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR9—Crohn's disease	0.000467	0.00571	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000465	0.00569	CbGpPWpGaD
Zafirlukast—Asthenia—Mesalazine—Crohn's disease	0.000464	0.00366	CcSEcCtD
Zafirlukast—Pruritus—Mesalazine—Crohn's disease	0.000457	0.00361	CcSEcCtD
Zafirlukast—Vomiting—Azathioprine—Crohn's disease	0.000451	0.00356	CcSEcCtD
Zafirlukast—Rash—Azathioprine—Crohn's disease	0.000447	0.00353	CcSEcCtD
Zafirlukast—Dermatitis—Azathioprine—Crohn's disease	0.000447	0.00353	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR6—Crohn's disease	0.000446	0.00545	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000445	0.00544	CbGpPWpGaD
Zafirlukast—Headache—Azathioprine—Crohn's disease	0.000444	0.00351	CcSEcCtD
Zafirlukast—Diarrhoea—Mesalazine—Crohn's disease	0.000442	0.00349	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—GPR65—Crohn's disease	0.000434	0.00531	CbGpPWpGaD
Zafirlukast—Dizziness—Mesalazine—Crohn's disease	0.000427	0.00338	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000427	0.00521	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000422	0.00516	CbGpPWpGaD
Zafirlukast—Nausea—Azathioprine—Crohn's disease	0.000421	0.00333	CcSEcCtD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000417	0.0051	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000414	0.00506	CbGpPWpGaD
Zafirlukast—Vomiting—Mesalazine—Crohn's disease	0.000411	0.00325	CcSEcCtD
Zafirlukast—Rash—Mesalazine—Crohn's disease	0.000407	0.00322	CcSEcCtD
Zafirlukast—Dermatitis—Mesalazine—Crohn's disease	0.000407	0.00322	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000406	0.00496	CbGpPWpGaD
Zafirlukast—Headache—Mesalazine—Crohn's disease	0.000405	0.0032	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000398	0.00486	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—PTGER4—Crohn's disease	0.000393	0.0048	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Prednisone—Crohn's disease	0.000389	0.00307	CcSEcCtD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000384	0.0047	CbGpPWpGaD
Zafirlukast—Nausea—Mesalazine—Crohn's disease	0.000384	0.00303	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—Crohn's disease	0.000383	0.00302	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—MLN—Crohn's disease	0.000381	0.00465	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR9—Crohn's disease	0.000381	0.00465	CbGpPWpGaD
Zafirlukast—Malaise—Prednisone—Crohn's disease	0.000378	0.00298	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—ACKR2—Crohn's disease	0.000365	0.00446	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000357	0.00437	CbGpPWpGaD
Zafirlukast—Myalgia—Prednisone—Crohn's disease	0.000357	0.00282	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—Crohn's disease	0.000357	0.00282	CcSEcCtD
Zafirlukast—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	0.000355	0.00434	CbGpPWpGaD
Zafirlukast—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000354	0.00433	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—GPR65—Crohn's disease	0.000354	0.00433	CbGpPWpGaD
Zafirlukast—Discomfort—Prednisone—Crohn's disease	0.000352	0.00278	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR9—Crohn's disease	0.000346	0.00422	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MLN—Crohn's disease	0.000346	0.00422	CbGpPWpGaD
Zafirlukast—Oedema—Prednisone—Crohn's disease	0.000342	0.0027	CcSEcCtD
Zafirlukast—Infection—Prednisone—Crohn's disease	0.00034	0.00268	CcSEcCtD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000329	0.00402	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—GPR65—Crohn's disease	0.000321	0.00393	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000311	0.00246	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—ACKR2—Crohn's disease	0.000311	0.0038	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR6—Crohn's disease	0.000309	0.00378	CbGpPWpGaD
Zafirlukast—Insomnia—Prednisone—Crohn's disease	0.000309	0.00244	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—Crohn's disease	0.000301	0.00238	CcSEcCtD
Zafirlukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.000296	0.00362	CbGpPWpGaD
Zafirlukast—Fatigue—Prednisone—Crohn's disease	0.000295	0.00233	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—MLN—Crohn's disease	0.000295	0.0036	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000293	0.00358	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	0.000288	0.00352	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Prednisone—Crohn's disease	0.000282	0.00223	CcSEcCtD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.00028	0.00342	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Prednisone—Crohn's disease	0.00028	0.00221	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000279	0.00341	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.000272	0.00333	CbGpPWpGaD
Zafirlukast—Urticaria—Prednisone—Crohn's disease	0.000272	0.00215	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—Crohn's disease	0.00027	0.00214	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—Crohn's disease	0.00027	0.00214	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—TAGAP—Crohn's disease	0.000269	0.00329	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR9—Crohn's disease	0.000264	0.00322	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR6—Crohn's disease	0.000252	0.00308	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Prednisone—Crohn's disease	0.000252	0.00199	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—Crohn's disease	0.000245	0.00194	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GPR65—Crohn's disease	0.000245	0.003	CbGpPWpGaD
Zafirlukast—Pruritus—Prednisone—Crohn's disease	0.000242	0.00191	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR9—Crohn's disease	0.00024	0.00293	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RSPO3—Crohn's disease	0.000235	0.00288	CbGpPWpGaD
Zafirlukast—Diarrhoea—Prednisone—Crohn's disease	0.000234	0.00185	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	0.000232	0.00284	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000229	0.0028	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR6—Crohn's disease	0.000229	0.0028	CbGpPWpGaD
Zafirlukast—Dizziness—Prednisone—Crohn's disease	0.000226	0.00179	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—SEL1L—Crohn's disease	0.000223	0.00273	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GPR65—Crohn's disease	0.000223	0.00272	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000222	0.00271	CbGpPWpGaD
Zafirlukast—Vomiting—Prednisone—Crohn's disease	0.000217	0.00172	CcSEcCtD
Zafirlukast—Rash—Prednisone—Crohn's disease	0.000216	0.0017	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling Pathways—ACKR2—Crohn's disease	0.000215	0.00263	CbGpPWpGaD
Zafirlukast—Dermatitis—Prednisone—Crohn's disease	0.000215	0.0017	CcSEcCtD
Zafirlukast—Headache—Prednisone—Crohn's disease	0.000214	0.00169	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR9—Crohn's disease	0.000204	0.0025	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MLN—Crohn's disease	0.000204	0.0025	CbGpPWpGaD
Zafirlukast—Nausea—Prednisone—Crohn's disease	0.000203	0.0016	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000203	0.00248	CbGpPWpGaD
Zafirlukast—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000202	0.00248	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTGER4—Crohn's disease	0.000202	0.00246	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	0.000201	0.00245	CbGpPWpGaD
Zafirlukast—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000197	0.0024	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000194	0.00237	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GPR65—Crohn's disease	0.00019	0.00232	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL3—Crohn's disease	0.000189	0.00231	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000189	0.00231	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TAGAP—Crohn's disease	0.000187	0.00228	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	0.000187	0.00228	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000183	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR6—Crohn's disease	0.000175	0.00214	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.000173	0.00212	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL3—Crohn's disease	0.000172	0.0021	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000172	0.0021	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000169	0.00206	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000166	0.00203	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RSPO3—Crohn's disease	0.000163	0.002	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR6—Crohn's disease	0.000159	0.00194	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.000155	0.00189	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SEL1L—Crohn's disease	0.000155	0.00189	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000154	0.00188	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL8—Crohn's disease	0.000144	0.00176	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000143	0.00175	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000143	0.00175	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	0.000143	0.00175	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000142	0.00174	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000142	0.00173	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000142	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR9—Crohn's disease	0.000142	0.00173	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000141	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTGER4—Crohn's disease	0.00014	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR6—Crohn's disease	0.000135	0.00165	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000132	0.00162	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GPR65—Crohn's disease	0.000132	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL3—Crohn's disease	0.000131	0.0016	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000131	0.0016	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000131	0.0016	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000127	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000127	0.00155	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.000125	0.00153	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RBX1—Crohn's disease	0.000122	0.0015	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000121	0.00147	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2RA—Crohn's disease	0.00012	0.00147	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTGER4—Crohn's disease	0.000119	0.00146	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL3—Crohn's disease	0.000119	0.00145	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000116	0.00142	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000115	0.00141	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000113	0.00139	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000112	0.00136	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000109	0.00133	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—UBE2D1—Crohn's disease	0.000107	0.00131	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000105	0.00128	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RIPK2—Crohn's disease	0.000104	0.00127	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000103	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL3—Crohn's disease	0.000101	0.00124	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.99e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL8—Crohn's disease	9.96e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.93e-05	0.00121	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	9.85e-05	0.0012	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RASGRP1—Crohn's disease	9.81e-05	0.0012	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.72e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	9.45e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR6—Crohn's disease	9.37e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	9.31e-05	0.00114	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	9.26e-05	0.00113	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2RA—Crohn's disease	9.18e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—JAK2—Crohn's disease	8.9e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SOCS1—Crohn's disease	8.89e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.86e-05	0.00108	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.84e-05	0.00108	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.83e-05	0.00108	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	8.79e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RBX1—Crohn's disease	8.48e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TYK2—Crohn's disease	8.47e-05	0.00104	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	8.45e-05	0.00103	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2RA—Crohn's disease	8.34e-05	0.00102	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.26e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTGER4—Crohn's disease	8.25e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL8—Crohn's disease	8.12e-05	0.000993	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—JAK2—Crohn's disease	8.08e-05	0.000988	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PLA2G4F—Crohn's disease	7.81e-05	0.000955	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SMAD3—Crohn's disease	7.67e-05	0.000938	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.57e-05	0.000925	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.53e-05	0.000921	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PLA2G4F—Crohn's disease	7.5e-05	0.000917	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—UBE2D1—Crohn's disease	7.43e-05	0.000909	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL8—Crohn's disease	7.38e-05	0.000902	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.21e-05	0.000881	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RIPK2—Crohn's disease	7.21e-05	0.000881	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2RA—Crohn's disease	7.1e-05	0.000868	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL3—Crohn's disease	7.03e-05	0.000859	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	6.82e-05	0.000833	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RASGRP1—Crohn's disease	6.8e-05	0.000831	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.75e-05	0.000825	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTMR3—Crohn's disease	6.64e-05	0.000812	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.44e-05	0.000787	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.44e-05	0.000787	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTMR3—Crohn's disease	6.38e-05	0.00078	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	6.38e-05	0.00078	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	6.38e-05	0.00078	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—JAK2—Crohn's disease	6.17e-05	0.000754	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SOCS1—Crohn's disease	6.16e-05	0.000753	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.03e-05	0.000737	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TYK2—Crohn's disease	5.87e-05	0.000718	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.87e-05	0.000717	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL8—Crohn's disease	5.63e-05	0.000688	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	5.61e-05	0.000686	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—JAK2—Crohn's disease	5.6e-05	0.000685	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.5e-05	0.000672	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SMAD3—Crohn's disease	5.32e-05	0.00065	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—FADS1—Crohn's disease	5.17e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL8—Crohn's disease	5.11e-05	0.000625	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.01e-05	0.000613	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TYK2—Crohn's disease	5.01e-05	0.000612	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—FADS1—Crohn's disease	4.97e-05	0.000608	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2RA—Crohn's disease	4.92e-05	0.000602	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	4.85e-05	0.000593	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPX4—Crohn's disease	4.85e-05	0.000592	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—JAK2—Crohn's disease	4.77e-05	0.000584	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTMR3—Crohn's disease	4.77e-05	0.000583	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.7e-05	0.000574	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GCKR—Crohn's disease	4.68e-05	0.000572	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPX4—Crohn's disease	4.66e-05	0.000569	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GCKR—Crohn's disease	4.5e-05	0.00055	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL8—Crohn's disease	4.36e-05	0.000533	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.33e-05	0.000529	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—Crohn's disease	4.14e-05	0.000507	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTMR3—Crohn's disease	4.12e-05	0.000504	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.98e-05	0.000487	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.95e-05	0.000482	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—FADS1—Crohn's disease	3.72e-05	0.000454	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.68e-05	0.00045	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—Crohn's disease	3.5e-05	0.000428	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX4—Crohn's disease	3.48e-05	0.000425	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TYK2—Crohn's disease	3.47e-05	0.000424	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.38e-05	0.000414	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.37e-05	0.000412	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GCKR—Crohn's disease	3.36e-05	0.000411	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTMR3—Crohn's disease	3.35e-05	0.00041	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—JAK2—Crohn's disease	3.31e-05	0.000405	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.21e-05	0.000393	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—FADS1—Crohn's disease	3.21e-05	0.000393	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.18e-05	0.000389	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—Crohn's disease	3.02e-05	0.000369	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX4—Crohn's disease	3.01e-05	0.000368	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GCKR—Crohn's disease	2.9e-05	0.000355	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—Crohn's disease	2.87e-05	0.000351	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.87e-05	0.00035	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—FADS1—Crohn's disease	2.87e-05	0.00035	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.81e-05	0.000344	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX4—Crohn's disease	2.68e-05	0.000328	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—FADS1—Crohn's disease	2.64e-05	0.000322	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—FADS1—Crohn's disease	2.61e-05	0.00032	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.6e-05	0.000318	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GCKR—Crohn's disease	2.59e-05	0.000317	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX4—Crohn's disease	2.47e-05	0.000302	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—Crohn's disease	2.45e-05	0.000299	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX4—Crohn's disease	2.45e-05	0.000299	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—Crohn's disease	2.43e-05	0.000297	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GCKR—Crohn's disease	2.38e-05	0.000291	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GCKR—Crohn's disease	2.36e-05	0.000289	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FADS1—Crohn's disease	2.23e-05	0.000273	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.21e-05	0.00027	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX4—Crohn's disease	2.09e-05	0.000256	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.08e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GCKR—Crohn's disease	2.02e-05	0.000247	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.85e-05	0.000226	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.82e-05	0.000222	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FADS1—Crohn's disease	1.72e-05	0.000211	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—Crohn's disease	1.7e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.69e-05	0.000206	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.62e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX4—Crohn's disease	1.61e-05	0.000197	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCKR—Crohn's disease	1.56e-05	0.000191	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—Crohn's disease	1.49e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.48e-05	0.000181	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.44e-05	0.000176	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—Crohn's disease	1.43e-05	0.000175	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—Crohn's disease	1.3e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.26e-05	0.000154	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—Crohn's disease	1.25e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—Crohn's disease	1.07e-05	0.000131	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—Crohn's disease	9.35e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—Crohn's disease	9.24e-06	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—Crohn's disease	8.25e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—Crohn's disease	8.09e-06	9.89e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—Crohn's disease	7.59e-06	9.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—Crohn's disease	7.52e-06	9.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—Crohn's disease	7.22e-06	8.82e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.64e-06	8.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—Crohn's disease	6.58e-06	8.05e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—Crohn's disease	6.43e-06	7.86e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.62e-06	6.88e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—Crohn's disease	4.96e-06	6.06e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.34e-06	5.31e-05	CbGpPWpGaD
